Girish Venkatachaliah Joins as CPT Officer for Decision Resources Group
Executive Team Addition Reinforces Increased Investment in AI, Machine Learning and Analytics-Enabled Solutions to Improve Patient Access and Outcomes
Decision Resources Group (DRG), a premier provider of data, analytics and insights products and services to the healthcare industry, announced the appointment of Girish Venkatachaliah as its new Chief Product & Technology Officer. Girish will lead DRG’s continued development of AI enabled integrated solutions designed to help life sciences, payers, and providers understand and engage the healthcare consumer in ways that improve health outcomes.
Girish joins DRG following his role as the Vice President of Data Strategy, Analytics and AI/ML at athenahealth where he led the strategy, research, product management, and engineering teams and pioneered unique uses of data and AI for provider efficiency. Prior to his role at athenahealth, Girish was the Vice President of product development at IBM responsible for a portfolio of cloud offerings including, Watson Machine Learning & persistence in the Watson Data Platform. Over his 17-year career at IBM, he held a variety of executive roles in the data, analytics and AI/ML.
“The addition of Girish’s extensive experience in Data and AI, coupled with his strong business leadership and strategic acumen, will be critical to our next level of success,” said Vivek Sharma, CEO DRG. “His deep knowledge of leading methods to solve healthcare challenges will serve to enhance our vision of advancing a global healthcare industry in which all organizations are insights and intelligence enabled. Together with our customers, we can speed up innovative treatments and better care.”
DRG has undergone a transformation from a syndicated market research company into a data-infused pioneer illuminating the challenges and opportunities present within the global healthcare ecosystem. This transformation has helped to accelerate business growth and expand product and services offerings for the fast-changing life sciences industry. DRG’s continuing investment in AI and machine learning on top of its platform of real-world data and industry leading insights positions the company to support the industry’s ever-growing need to engage with consumers in new ways, avoid barriers to access and adherence, and respond more quickly to unmet need.